Common Diabetes Drug May Trigger Rare Complications for Covid-19 Patients, Say Scientists

According to researchers from Brigham and Women’s Hospital in the US, the condition known as diabetic ketoacidosis (DKA), can arise when illness prevents cells from receiving enough glucose to fuel their functioning.